Roanoke Asset Management Corp Amgen Inc Transaction History

Roanoke Asset Management Corp

$318 Million
Q3 2024

A detailed history of Roanoke Asset Management Corp transactions in Amgen Inc stock. As of the latest transaction made, Roanoke Asset Management Corp holds 4,155 shares of AMGN stock, worth $1.16 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

4,155

Previous 4,155 -0.0%

Holding current value

$1.16 Million

Previous $1.3 Million 3.16%

% of portfolio

0.42%

Previous 0.43%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$268.87 - $324.56 $185,520 - $223,946	690 Added 19.91%	4,155 $1.18 Million
Q4 2023 Feb 08, 2024	BUY	$255.7 - $288.46 $25,570 - $28,845	100 Added 2.97%	3,465 $998,000
Q3 2023 Nov 15, 2023	BUY	$218.65 - $271.46 $147,588 - $183,235	675 Added 25.09%	3,365 $904,000
Q1 2022 May 11, 2022	SELL	$219.27 - $242.57 $1.91 Million - $2.11 Million	-8,718 Reduced 76.42%	2,690 $650,000
Q4 2021 Feb 09, 2022	SELL	$198.88 - $227.6 $12,927 - $14,794	-65 Reduced 0.57%	11,408 $2.57 Million
Q3 2021 Nov 03, 2021	SELL	$212.27 - $248.7 $61,558 - $72,123	-290 Reduced 2.47%	11,473 $2.44 Million
Q2 2021 Jul 28, 2021	BUY	$233.58 - $259.14 $475,335 - $527,349	2,035 Added 20.92%	11,763 $2.87 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $3,328 - $3,879	-15 Reduced 0.15%	9,728 $2.42 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $28,129 - $33,497	-130 Reduced 1.32%	9,743 $2.24 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $2,346 - $2,609	10 Added 0.1%	9,873 $2.51 Million
Q2 2020 Aug 05, 2020	SELL	$197.81 - $242.74 $209,876 - $257,547	-1,061 Reduced 9.71%	9,863 $2.33 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $11,845 - $15,710	-65 Reduced 0.59%	10,924 $2.22 Million
Q4 2019 Feb 05, 2020	SELL	$189.21 - $243.2 $502,352 - $645,696	-2,655 Reduced 19.46%	10,989 $2.65 Million
Q3 2019 Nov 01, 2019	SELL	$174.11 - $208.62 $11,317 - $13,560	-65 Reduced 0.47%	13,644 $2.64 Million
Q2 2019 Jul 19, 2019	SELL	$166.7 - $195.41 $1,667 - $1,954	-10 Reduced 0.07%	13,709 $2.53 Million
Q1 2019 Apr 29, 2019	SELL	$180.87 - $203.88 $9,043 - $10,194	-50 Reduced 0.36%	13,719 $2.61 Million
Q4 2018 Feb 06, 2019	SELL	$178.4 - $208.25 $39,248 - $45,815	-220 Reduced 1.57%	13,769 $2.68 Million
Q3 2018 Oct 30, 2018	SELL	$185.29 - $208.89 $1,667 - $1,880	-9 Reduced 0.06%	13,989 $2.9 Million
Q2 2018 Jul 25, 2018	SELL	$166.05 - $186.51 $177,673 - $199,565	-1,070 Reduced 7.1%	13,998 $2.58 Million
Q1 2018 Apr 19, 2018	SELL	$169.43 - $198.0 $749,727 - $876,150	-4,425 Reduced 22.7%	15,068 $2.57 Million
Q4 2017 Jan 29, 2018	SELL	$168.79 - $188.59 $333,360 - $372,465	-1,975 Reduced 9.2%	19,493 $3.39 Million
Q3 2017 Oct 20, 2017	BUY	$167.29 - $191.0 $3.59 Million - $4.1 Million	21,468	21,468 $4 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roanoke Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Roanoke Asset Management Corp with notifications on news.

Account

Roanoke Asset Management Corp Amgen Inc Transaction History